Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Unrelated Allogeneic Stem Cell Transplantation with Myeloablative Conditioning in Adults with Acute Lymphoblastic Leukemia in Remission: Peripheral Blood or Bone Marrow?.

Nadezda Basara, MD, DSc, Myriam Labopin, MD, PhD, Tapani Ruutu, MD, Axel Zander, MD, Oliver Ottmann, MD, Renate Arnold, MD, Vanderson Rocha, MD

Blood (2007) 110 (11): 174.

https://doi.org/10.1182/blood.V110.11.174.174

Published: 2007

Journal Articles

Antifungal Prophylaxis in Allogeneic Stem Cell Transplantation: Results of a Retrospective Cohort Study.

Christine Wolschke, MD, Heinrich Lellek, MD, Marion Heinzelmann, RN, Nicolaus Kroeger, MD, Axel Zander, MD

Blood (2007) 110 (11): 5004.

https://doi.org/10.1182/blood.V110.11.5004.5004

Published: 2007

Journal Articles

Dose-Reduced Conditioning Followed by Allogeneic Stem Cell Transplantation in Patients with Myelofibrosis. Results from a Multicenter Prospective Trial of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

Blood (2007) 110 (11): 683.

https://doi.org/10.1182/blood.V110.11.683.683

Published: 2007

Journal Articles

Unrelated Allogeneic Stem Cell Transplantation with Myeloablative Preparative Regimen for Adult Patients with Acute Lymphoblastic Leukemia in CR: A Survey from the European Group for Blood and Marrow Transplantation (EBMT).

Nadezda Basara, MD, DSc, Myriam Labopin, MD, PhD, Tapani Ruutu, MD, Axel Zander, MD, Renate Arnold, MD, Vanderson Rocha, MD, PhD

Blood (2006) 108 (11): 3112.

https://doi.org/10.1182/blood.V108.11.3112.3112

Published: 2006

Journal Articles

Rapid Regression of Bone Marrow Fibrosis after Dose-Reduced Allogeneic Stem Cell Transplantation in Patients with Myelofibrosis.

Nicolaus Kroeger, MD, Juergen Thiele, MD, Axel Zander, MD, Michael Kvasnicka, MD

Blood (2006) 108 (11): 374.

https://doi.org/10.1182/blood.V108.11.374.374

Published: 2006

Journal Articles

Highly Sensitive Real-Time PCR of V617F-JAK2-Mutation To Monitor Minimal Residual Disease and Guide Donor Lymphocte Infusion after Allogeneic Stem Cell Transplantation in Patients with Myelofibrosis.

Nicolaus Kroeger, MD, Anita Badbaran, Ernst Holler, MD, Joachim Hahn, MD, Guido Kobbe, MD, Martin Bornhauser, MD, Andreas Reiter, MD, Tatjana Zabelina, MD, Axel Zander, MD, Boris Fehse, MD

Blood (2006) 108 (11): 669.

https://doi.org/10.1182/blood.V108.11.669.669

Published: 2006

Journal Articles

Serum Free Light Chain [FLC] Assay in Multiple Myeloma Patients Who Achieved Negative Immunofixation after Allogeneic Stem Cell Transplantation.

Ulrike Moesbauer, Heike Schieder, MD, Helmut Renges, MD, Francis Ayuk, MD, Axel Zander, MD, Nicolaus Kröger, MD

Blood (2005) 106 (11): 2023.

https://doi.org/10.1182/blood.V106.11.2023.2023

Published: 2005

Journal Articles

Donor KIR Haplotype Genes Significantly Influence Disease-Free and Overall Survival after Myeloablative Conditioning Followed by In Vivo T-Cell Depleted [ATG] Unrelated Stem Cell Transplantation.

Nicolaus Kroeger, MD, Thomas Binder, MD, PhD, Heike Schieder, MD, Helmut Renges, MD, Francis Ayuk, MD, Christine Wolschke, MD, Thomas H. Eiermann, MD, PhD, Axel Zander, MD

Blood (2005) 106 (11): 2040.

https://doi.org/10.1182/blood.V106.11.2040.2040

Published: 2005

Journal Articles

Kinetics of Plasma-Cell Chimerism after Allogeneic Stem Cell Transplantation by Real-Time PCR and Its Value To Quantify Minimal Residual Disease in Patients with Multiple Myeloma.

Nicolaus Kroeger, MD, Maria Zagrivnaja, PhD, Sabine Schwartz, Anita Badbaran, Tatjana Zabelina, MD, Francis Ayuk, MD, Axel Zander, MD, Boris Fehse, PhD

Blood (2005) 106 (11): 2748.

https://doi.org/10.1182/blood.V106.11.2748.2748

Published: 2005

Journal Articles

Collaborative RISC-Score Database: Creation of an International Database for Retroviral Integration Analysis.

Stephanie Laufs, Phd, Frank Giordano, Daniel Lauterborn, K. Zsuzsanna Nagy, Kurt Fellernberg, Phd, Agnes Hotz-Wagenblatt, Phd, Guillermo Guenechea, Phd, Boris Fehse, Phd, Juan B. Bueren, Phd, Axel Zander, MD, Cynthia E. Dunbar, MD, W. Jens Zeller, MD, Stefan Fruehauf, MD

Blood (2004) 104 (11): 2110.

https://doi.org/10.1182/blood.V104.11.2110.2110

Published: 2004

Journal Articles

Hematopoietic Stem-Cell Transplantation from Unrelated Donors in Elderly Patients (> 55 Years): Older Age Is No Longer a Contraindication When Using Reduced Intensity Conditioning.

Avichai Shimoni, MD, Nicolaus Kröger, MD, Tatjana Zabelina, MD, Frances Ayuk, MD, Izhar Hardan, MD, Moshe Yeshurun, MD, Noga Shem-Tov, MD, Abraham Avigdor, MD, Isacc Ben-Bassat, MD, Axel Zander, MD, Arnon Nagler, MD

Blood (2004) 104 (11): 2750.

https://doi.org/10.1182/blood.V104.11.2750.2750

Published: 2004

Journal Articles

Allogeneic Stem Cell Transplantation from Unrelated Donors after Reduced Intensity Conditioning in Patients with MDS/sAML. A Report from the Chronic Leukemia Working Party (CLWP) of the EBMT.

Nicolaus Kroeger, MD, Ronald Brand, PhD, Rodrigo Martino, MD, Philippe Guardiola, MD, Anja van Biezen, Axel Zander, MD, Dietger Niederwieser, MD, Theo De Witte, MD

Blood (2004) 104 (11): 5176.

https://doi.org/10.1182/blood.V104.11.5176.5176

Published: 2004

Journal Articles

Pilot Study of Reduced-Intensity Conditioning Followed by Allogeneic Stem Cell Transplantation in Patients with Myelofibrosis.

Nicolaus Kroeger, MD, Tatjana Zabelina, MD, Heike Schieder, MD, Jens Panse, MD, Francis Ayuk, MD, Natalja Fehse, MD, Boris Fehse, MD, Olga Waschke, MD, Hans M. Kvasnicka, MD, Jurgen Thiele, MD, Axel Zander, MD

Blood (2004) 104 (11): 1512.

https://doi.org/10.1182/blood.V104.11.1512.1512

Published: 2004

Journal Articles

Low Dose Thalidomide and Donor Lymphocyte Infusion as Adoptive Immunotherapy after Allogeneic Stem Cell Transplantation in Patients with Multiple Myeloma.

Nicolaus Kroeger, MD, Avichai Shimoni, MD, Maria Zagrivnaja, PhD, Francis Ayuk, MD, Michael Lioznov, PhD, Heike Schieder, MD, Boris Fehse, PhD, Tatjana Zabelina, MD, Arnon Nagler, MD, Axel Zander, MD

Blood (2004) 104 (11): 1646.

https://doi.org/10.1182/blood.V104.11.1646.1646

Published: 2004

NARROW

Unrelated Allogeneic Stem Cell Transplantation with Myeloablative Conditioning in Adults with Acute Lymphoblastic Leukemia in Remission: Peripheral Blood or Bone Marrow?.

Antifungal Prophylaxis in Allogeneic Stem Cell Transplantation: Results of a Retrospective Cohort Study.

Dose-Reduced Conditioning Followed by Allogeneic Stem Cell Transplantation in Patients with Myelofibrosis. Results from a Multicenter Prospective Trial of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

Unrelated Allogeneic Stem Cell Transplantation with Myeloablative Preparative Regimen for Adult Patients with Acute Lymphoblastic Leukemia in CR: A Survey from the European Group for Blood and Marrow Transplantation (EBMT).

Rapid Regression of Bone Marrow Fibrosis after Dose-Reduced Allogeneic Stem Cell Transplantation in Patients with Myelofibrosis.

Highly Sensitive Real-Time PCR of V617F-JAK2-Mutation To Monitor Minimal Residual Disease and Guide Donor Lymphocte Infusion after Allogeneic Stem Cell Transplantation in Patients with Myelofibrosis.

Serum Free Light Chain [FLC] Assay in Multiple Myeloma Patients Who Achieved Negative Immunofixation after Allogeneic Stem Cell Transplantation.

Donor KIR Haplotype Genes Significantly Influence Disease-Free and Overall Survival after Myeloablative Conditioning Followed by In Vivo T-Cell Depleted [ATG] Unrelated Stem Cell Transplantation.

Kinetics of Plasma-Cell Chimerism after Allogeneic Stem Cell Transplantation by Real-Time PCR and Its Value To Quantify Minimal Residual Disease in Patients with Multiple Myeloma.

Collaborative RISC-Score Database: Creation of an International Database for Retroviral Integration Analysis.

Hematopoietic Stem-Cell Transplantation from Unrelated Donors in Elderly Patients (> 55 Years): Older Age Is No Longer a Contraindication When Using Reduced Intensity Conditioning.

Allogeneic Stem Cell Transplantation from Unrelated Donors after Reduced Intensity Conditioning in Patients with MDS/sAML. A Report from the Chronic Leukemia Working Party (CLWP) of the EBMT.

Pilot Study of Reduced-Intensity Conditioning Followed by Allogeneic Stem Cell Transplantation in Patients with Myelofibrosis.

Low Dose Thalidomide and Donor Lymphocyte Infusion as Adoptive Immunotherapy after Allogeneic Stem Cell Transplantation in Patients with Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only